• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能减退的肾病性特发性膜性肾病肾脏预后的病理预测指标

Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.

作者信息

Chen Yizhi, Tang Li, Feng Zhe, Cao Xueying, Sun Xuefeng, Liu Moyan, Liu Shuwen, Zhang Xueguang, Li Ping, Wei Ribao, Qiu Qiang, Cai Guangyan, Chen Xiangmei

机构信息

Division of Nephrology, State Key Discipline of Internal Medicine (Nephrology), State Key Laboratory of Kidney Disease (2011DAV00088), National Clinical Medical Research Center for Kidney Disease (2013BAI09B05), Medical Quality Control Center for Kidney Disease, Chinese People's Liberation Army (PLA) General Hospital (301 Hospital), Chinese PLA Medical Academy, 28 Fuxing Road, Haidian District, Beijing, 100853, People's Republic of China.

出版信息

J Nephrol. 2014 Jun;27(3):307-16. doi: 10.1007/s40620-014-0057-0. Epub 2014 Feb 13.

DOI:10.1007/s40620-014-0057-0
PMID:24523071
Abstract

BACKGROUND AND OBJECTIVES

The outcome of idiopathic membranous nephropathy (IMN) in adults with nephrotic-range proteinuria and decreased renal function has seldom been described and the predictive value of pathological features is debated. This study aimed to describe the clinical course of this patient subgroup and to identify independently predictive pathological features.

MATERIALS AND METHODS

We evaluated 129 adults with biopsy-proven IMN diagnosed from 2002 to 2011. All patients had chronic kidney disease (CKD) stages 2-4 and nephrotic-range proteinuria (≥3.5 g/day). Primary outcomes were a 20 or 50 % decline in renal function, progression to end-stage renal disease (ESRD), or all-cause mortality.

RESULTS

Of 129 patients, 38 (30 %) presented with proteinuria ≥8.0 g/day and 37 (29 %) with CKD stages 3-4. Thirteen (10 %) presented with segmental sclerosis, 97 (75 %) with arteriosclerosis, 42 (33 %) with moderate-to-severe tubulointerstitial injury, and 86 (67 %) with C3 deposition. Over a median follow-up of 34 months (range 12-135), 51 patients (40 %) had a 20 % decline in renal function, 27 (21 %) a 50 % decline, 14 (11 %) developed ESRD, and 19 (15 %) died. Segmental sclerosis and tubulointerstitial injury but not arteriosclerosis or C3 deposition were independent risk factors for 20 and 50 % renal function decline and progression to ESRD.

CONCLUSIONS

Segmental sclerosis and tubulointerstitial injury predict renal outcomes independent of clinical data in nephrotic IMN patients with decreased renal function.

摘要

背景与目的

关于成人特发性膜性肾病(IMN)伴肾病范围蛋白尿及肾功能减退的预后情况鲜有描述,且病理特征的预测价值存在争议。本研究旨在描述该患者亚组的临床病程,并确定具有独立预测性的病理特征。

材料与方法

我们评估了129例于2002年至2011年经活检证实为IMN的成人患者。所有患者均处于慢性肾脏病(CKD)2 - 4期且有肾病范围蛋白尿(≥3.5 g/天)。主要结局为肾功能下降20%或50%、进展至终末期肾病(ESRD)或全因死亡。

结果

129例患者中,38例(30%)蛋白尿≥8.0 g/天,37例(29%)处于CKD 3 - 4期。13例(10%)出现节段性硬化,97例(75%)出现动脉硬化,42例(33%)出现中至重度肾小管间质损伤,86例(67%)出现C3沉积。中位随访34个月(范围12 - 135个月),51例患者(40%)肾功能下降20%,27例(21%)下降50%,14例(11%)进展为ESRD,19例(15%)死亡。节段性硬化和肾小管间质损伤而非动脉硬化或C3沉积是肾功能下降20%和50%以及进展至ESRD的独立危险因素。

结论

在肾功能减退的肾病性IMN患者中,节段性硬化和肾小管间质损伤可独立于临床数据预测肾脏结局。

相似文献

1
Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.肾功能减退的肾病性特发性膜性肾病肾脏预后的病理预测指标
J Nephrol. 2014 Jun;27(3):307-16. doi: 10.1007/s40620-014-0057-0. Epub 2014 Feb 13.
2
[Idiopathic membranous nephropathy with focal segmental sclerosis].[伴局灶节段性硬化的特发性膜性肾病]
Ter Arkh. 2024 Jul 7;96(6):580-586. doi: 10.26442/00403660.2024.06.202725.
3
The natural history of the non-nephrotic membranous nephropathy patient.非肾病性膜性肾病患者的自然病程。
Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.
4
Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.尿N-乙酰-β-氨基葡萄糖苷酶和估计的肾小球滤过率可能有助于识别特发性膜性肾病诊断时需要接受免疫抑制治疗的患者。
Nephrology (Carlton). 2018 Feb;23(2):175-182. doi: 10.1111/nep.12952.
5
Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.局灶节段性肾小球硬化症,不包括非典型病变,是膜性肾病患者肾脏结局的预测指标:对 716 例患者的回顾性分析。
BMC Nephrol. 2019 Aug 22;20(1):328. doi: 10.1186/s12882-019-1498-4.
6
ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.血管紧张素转换酶抑制剂可改善特发性膜性肾病和持续性肾病综合征患者的肾小球大小选择性。
Am J Kidney Dis. 2000 Mar;35(3):381-91. doi: 10.1016/s0272-6386(00)70190-9.
7
Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.日本特发性膜性肾病合并肾病综合征的预后及危险因素
Kidney Int. 2004 Apr;65(4):1400-7. doi: 10.1111/j.1523-1755.2004.00518.x.
8
Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome.特发性膜性肾病肾病综合征患者的急性肾损伤。
Ren Fail. 2021 Dec;43(1):1004-1011. doi: 10.1080/0886022X.2021.1942913.
9
The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.环孢素治疗肾病综合征的缓解并不能减缓特发性膜性肾病的进展。
Clin Nephrol. 2004 Jan;61(1):17-24. doi: 10.5414/cnp61017.
10
Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.全球肾小球硬化伴肾病综合征;年龄调整的临床重要性。
Kidney Int. 2018 May;93(5):1175-1182. doi: 10.1016/j.kint.2017.09.028. Epub 2017 Dec 19.

引用本文的文献

1
Renal arteriolosclerosis impact on clinicopathological features and outcomes of idiopathic membranous nephropathy: a retrospective cohort analysis.肾小动脉硬化对特发性膜性肾病临床病理特征及预后的影响:一项回顾性队列分析
Front Med (Lausanne). 2025 May 21;12:1594990. doi: 10.3389/fmed.2025.1594990. eCollection 2025.
2
Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.特发性膜性肾病伴局灶节段性肾小球硬化病变可能需要积极治疗。
Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20230871. doi: 10.1590/1806-9282.20230871. eCollection 2024.
3
Proteomic analysis of glomeruli, tubules and renal interstitium in idiopathic membranous nephropathy (IMN): A statistically observational study.

本文引用的文献

1
Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.雷公藤(一种传统中药)用于原发性肾病综合征。
Cochrane Database Syst Rev. 2013 Aug 11(8):CD008568. doi: 10.1002/14651858.CD008568.pub2.
2
Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.来氟米特联合口服泼尼松治疗特发性膜性肾病:疗效和安全性的回顾性临床研究。
Nephrology (Carlton). 2013 Sep;18(9):615-22. doi: 10.1111/nep.12143.
3
Treatment of idiopathic membranous nephropathy.
特发性膜性肾病(IMN)肾小球、肾小管和肾间质的蛋白质组学分析:一项统计学观察性研究。
Medicine (Baltimore). 2023 Dec 15;102(50):e36476. doi: 10.1097/MD.0000000000036476.
4
Real-world study of the leakage of two types of infusion bags in multicenter pharmacy intravenous admixture service (PIVAS).两种输液袋在多中心静脉药物配置中心(PIVAS)渗漏情况的真实世界研究。
Front Pharmacol. 2023 Oct 6;14:1273020. doi: 10.3389/fphar.2023.1273020. eCollection 2023.
5
Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage.特发性膜性肾病伴肾小管间质性损害患者的临床特征和预后。
Ren Fail. 2023 Dec;45(1):2205951. doi: 10.1080/0886022X.2023.2205951.
6
From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?从 KDIGO 2012 到 KDIGO 2021 特发性膜性肾病指南:过去 10 年有哪些变化?
J Nephrol. 2023 Mar;36(2):551-561. doi: 10.1007/s40620-022-01493-9. Epub 2022 Nov 30.
7
Primary membranous nephropathy: an endless story.原发性膜性肾病:一个无尽的故事。
J Nephrol. 2023 Mar;36(2):563-574. doi: 10.1007/s40620-022-01461-3. Epub 2022 Oct 17.
8
Non-glomerular Tip Lesion Focal Segmental Glomerulosclerosis as a Negative Predictor in Idiopathic Membranous Nephropathy.特发性膜性肾病中非肾小球尖端病变局灶节段性肾小球硬化作为一个负预测因子。
Curr Med Sci. 2022 Oct;42(5):1007-1014. doi: 10.1007/s11596-022-2628-y. Epub 2022 Sep 30.
9
Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy.特发性膜性肾病患者体重指数与临床病理参数的相关性
Diabetes Metab Syndr Obes. 2022 Jun 20;15:1897-1909. doi: 10.2147/DMSO.S366100. eCollection 2022.
10
Membranous nephropathy: new pathogenic mechanisms and their clinical implications.膜性肾病:新的发病机制及其临床意义。
Nat Rev Nephrol. 2022 Jul;18(7):466-478. doi: 10.1038/s41581-022-00564-1. Epub 2022 Apr 28.
特发性膜性肾病的治疗。
Nat Rev Nephrol. 2013 Aug;9(8):443-58. doi: 10.1038/nrneph.2013.125. Epub 2013 Jul 2.
4
Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China.过去15年经活检证实的原发性肾小球疾病谱的变化:一项中国单中心研究
Contrib Nephrol. 2013;181:22-30. doi: 10.1159/000348638. Epub 2013 May 8.
5
Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population.中国人群特发性膜性肾病的长期预后及预后因素
Clin Nephrol. 2013 Jun;79(6):445-53. doi: 10.5414/CN107681.
6
Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.免疫抑制治疗膜性肾病:36 项临床试验的系统评价和荟萃分析。
Clin J Am Soc Nephrol. 2013 May;8(5):787-96. doi: 10.2215/CJN.07570712. Epub 2013 Feb 28.
7
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.免疫抑制治疗进展性膜性肾病:一项英国随机对照试验。
Lancet. 2013 Mar 2;381(9868):744-51. doi: 10.1016/S0140-6736(12)61566-9. Epub 2013 Jan 9.
8
Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy.特发性膜性肾病肾小球和肾小管间质形态计量学的预后意义。
Pathol Res Pract. 2012 Nov 15;208(11):662-7. doi: 10.1016/j.prp.2012.08.004. Epub 2012 Sep 17.
9
Rituximab in idiopathic membranous nephropathy.利妥昔单抗治疗特发性膜性肾病。
J Am Soc Nephrol. 2012 Aug;23(8):1416-25. doi: 10.1681/ASN.2012020181. Epub 2012 Jul 19.
10
Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center.特发性膜性肾病:在一家三级转诊中心随时间推移的临床和组织学预后特征及治疗模式。
Am J Nephrol. 2012;36(1):78-89. doi: 10.1159/000339628. Epub 2012 Jun 27.